跳至主要内容
临床试验/ISRCTN56578422
ISRCTN56578422已完成不适用

Antibiotic targeting of Wolbachia endosymbiotic bacteria as a new approach to the treatment of filarial (Wuchereria bancrofti) infection and disease

European Commission0 个研究点目标入组 240 人开始时间: 2006年2月22日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • For all participants: subjects of both sexes, aged 18-50 years, who have given informed consent (written or thumb print) were evaluated. Minimum criteria was body weight >40 kg. Participants were only included in case they met the following criteria: normal renal and hepatic laboratory profiles for aspartate aminotransferase (AST) (0-40 IU/l), alanine aminotransferase (ALT) (0-45 IU/l), creatinine 53-126 µmol/l) as measured by dipstick chemistry.
  • For microfilaraemic participants: minimum criteria was microfilarial (Mf) counts >50 Mf/ml (finger pricks taken from night blood between 8 and 10 p.m., counted through a blood counting chamber, e.g. Sedgewick®.
  • For patients with early or chronic signs of disease: microfilaraemic or amicrofilaraemic, clinical manifestation of hydrocele and/or lymphedema.

排除标准

  • 1. Pregnancy (pregnancy test)
  • 2. Lactation
  • 3. Intolerance to ivermectin or doxycycline
  • 4. Chronic diseases
  • 5. Alcohol or drug abuse
  • 6. Anti-filarial therapy within the last two years

研究者

相似试验